Hormone replacement therapy [topp]
blood lipids [lipd]
postmenopausal [tmco]
Women [popg]
Type 2 Diabetes [dsyn]
Limited [ftcn]
Concern [idcn]
influential [idcn]
Hormone replacement therapy [topp]
Lipid [lipd]
Profile [lbpr]
Women [popg]
Type 2 Diabetes [dsyn]
Study [mnob]
blood lipids [lipd]
Hormone replacement therapy [topp]
postmenopausal [tmco]
Women [popg]
Type 2 Diabetes [dsyn]
Seven [qnco]
Women [popg]
included [ftcn]
Study [mnob]
Assigned [ftcn]
4 groups [inpr]
base [inch]
diabetic [fndg]
Users [humn]
Estrogen [horm, phsu, strd]
Alone [qnco]
ERT [topp]
Estrogen [horm, phsu, strd]
Plus [qlco]
Progestin [horm, phsu, strd]
ERT [topp]
Oral [spco]
estradiol valerate 2 MG [clnd]
Estrogen [horm, phsu, strd]
Plus [qlco]
Progestin [horm, phsu, strd]
Oral [spco]
estradiol valerate 2 MG [clnd]
Combined [qlco]
Cyproterone Acetate [phsu, strd]
mg day [qnco]
Total Cholesterol [lbpr]
Low Density Lipoprotein Cholesterol [bacs, strd]
High Density Lipoprotein Cholesterol [bacs, lipd]
Triglycerides [bacs, lipd]
Lipoprotein (a) [aapp, bacs]
Lp(a) [aapp, bacs]
Assessed [acty]
Estrogen [horm, phsu, strd]
Plus [qlco]
Progestin [horm, phsu, strd]
ERT [topp]
Decrease [qlco]
High Density Lipoprotein Cholesterol [bacs, lipd]
Patients [podg]
Diabetes [dsyn]
P NOS [aapp, imft]
Cases [ftcn]
Decreased [qnco]
Women [popg]
Diabetes [dsyn]
P NOS [aapp, imft]
Cases [ftcn]
Lp(a) [aapp, bacs]
Reduced [qlco]
Estrogen [horm, phsu, strd]
Plus [qlco]
Progestin [horm, phsu, strd]
P NOS [aapp, imft]
ERT [topp]
P NOS [aapp, imft]
High Density Lipoprotein Cholesterol [bacs, lipd]
Increased [qnco]
P NOS [aapp, imft]
ERT [topp]
Unchanged [fndg]
Estrogen [horm, phsu, strd]
Plus [qlco]
Progestin [horm, phsu, strd]
Lipid [lipd]
Parameters [fndg]
Lp(a) [aapp, bacs]
ERT [topp]
Estrogen [horm, phsu, strd]
Plus [qlco]
Progestin [horm, phsu, strd]
postmenopausal [tmco]
Women [popg]
Type 2 Diabetes [dsyn]
